FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3150909418> ?p ?o ?g. }

• W3150909418 endingPage "239" @default.
• W3150909418 startingPage "232" @default.
• W3150909418 abstract "The impacts of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic on cancer care are multiple, entailing a high risk of death from coronavirus disease 2019 (COVID-19) in patients with cancer treated by chemotherapy. SARS-CoV-2 vaccines represent an opportunity to decrease the rate of severe COVID-19 cases in patients with cancer and also to restore normal cancer care. Patients with cancer to be targeted for vaccination are difficult to define owing to the limited contribution of these patients in the phase III trials testing the different vaccines. It seems appropriate to vaccinate not only patients with cancer with ongoing treatment or with a treatment having been completed less than 3 years ago but also household and close contacts. High-risk patients with cancer who are candidates for priority access to vaccination are those treated by chemotherapy. The very high-priority population includes patients with curative treatment and palliative first- or second-line chemotherapy, as well as patients requiring surgery or radiotherapy involving a large volume of lung, lymph node and/or haematopoietic tissue. When possible, vaccination should be carried out before cancer treatment begins. SARS-CoV-2 vaccination can be performed during chemotherapy while avoiding periods of neutropenia and lymphopenia. For organisational reasons, vaccination should be performed in cancer care centres with messenger RNA vaccines (or non-replicating adenoviral vaccines in non-immunocompromised patients). Considering the current state of knowledge, the benefit-risk ratio strongly favours SARS-CoV-2 vaccination of all patients with cancer. To obtain more data concerning the safety and effectiveness of vaccines, it is necessary to implement cohorts of vaccinated patients with cancer." @default.
• W3150909418 created "2021-04-13" @default.
• W3150909418 creator A5000308994 @default.
• W3150909418 creator A5002063921 @default.
• W3150909418 creator A5006830326 @default.
• W3150909418 creator A5009023321 @default.
• W3150909418 creator A5011185863 @default.
• W3150909418 creator A5011868732 @default.
• W3150909418 creator A5018287918 @default.
• W3150909418 creator A5022701871 @default.
• W3150909418 creator A5035492096 @default.
• W3150909418 creator A5037804882 @default.
• W3150909418 creator A5040688022 @default.
• W3150909418 creator A5040985815 @default.
• W3150909418 creator A5042202815 @default.
• W3150909418 creator A5054861001 @default.
• W3150909418 creator A5059592567 @default.
• W3150909418 creator A5066266071 @default.
• W3150909418 creator A5072348796 @default.
• W3150909418 creator A5074346281 @default.
• W3150909418 creator A5077000250 @default.
• W3150909418 creator A5081937285 @default.
• W3150909418 creator A5084815041 @default.
• W3150909418 creator A5085121407 @default.
• W3150909418 creator A5088044598 @default.
• W3150909418 creator A5089539215 @default.
• W3150909418 date "2021-06-01" @default.
• W3150909418 modified "2023-10-16" @default.
• W3150909418 title "Severe acute respiratory syndrome coronavirus 2 vaccination for patients with solid cancer: Review and point of view of a French oncology intergroup (GCO, TNCD, UNICANCER)" @default.
• W3150909418 cites W2134691437 @default.
• W3150909418 cites W2724264513 @default.
• W3150909418 cites W2944109443 @default.
• W3150909418 cites W3012666314 @default.
• W3150909418 cites W3016228656 @default.
• W3150909418 cites W3017770879 @default.
• W3150909418 cites W3023300354 @default.
• W3150909418 cites W3027070720 @default.
• W3150909418 cites W3030259932 @default.
• W3150909418 cites W3034144509 @default.
• W3150909418 cites W3041960835 @default.
• W3150909418 cites W3084004777 @default.
• W3150909418 cites W3091376205 @default.
• W3150909418 cites W3092131843 @default.
• W3150909418 cites W3093729476 @default.
• W3150909418 cites W3095689420 @default.
• W3150909418 cites W3097772705 @default.
• W3150909418 cites W3107586775 @default.
• W3150909418 cites W3111255098 @default.
• W3150909418 cites W3111590711 @default.
• W3150909418 cites W3113567260 @default.
• W3150909418 cites W3113685295 @default.
• W3150909418 cites W3116049377 @default.
• W3150909418 cites W3125405808 @default.
• W3150909418 cites W3126453280 @default.
• W3150909418 cites W3127329393 @default.
• W3150909418 cites W3130161221 @default.
• W3150909418 cites W4205483821 @default.
• W3150909418 doi "https://doi.org/10.1016/j.ejca.2021.03.030" @default.
• W3150909418 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8015403" @default.
• W3150909418 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33934060" @default.
• W3150909418 hasPublicationYear "2021" @default.
• W3150909418 type Work @default.
• W3150909418 sameAs 3150909418 @default.
• W3150909418 citedByCount "11" @default.
• W3150909418 countsByYear W31509094182021 @default.
• W3150909418 countsByYear W31509094182022 @default.
• W3150909418 countsByYear W31509094182023 @default.
• W3150909418 crossrefType "journal-article" @default.
• W3150909418 hasAuthorship W3150909418A5000308994 @default.
• W3150909418 hasAuthorship W3150909418A5002063921 @default.
• W3150909418 hasAuthorship W3150909418A5006830326 @default.
• W3150909418 hasAuthorship W3150909418A5009023321 @default.
• W3150909418 hasAuthorship W3150909418A5011185863 @default.
• W3150909418 hasAuthorship W3150909418A5011868732 @default.
• W3150909418 hasAuthorship W3150909418A5018287918 @default.
• W3150909418 hasAuthorship W3150909418A5022701871 @default.
• W3150909418 hasAuthorship W3150909418A5035492096 @default.
• W3150909418 hasAuthorship W3150909418A5037804882 @default.
• W3150909418 hasAuthorship W3150909418A5040688022 @default.
• W3150909418 hasAuthorship W3150909418A5040985815 @default.
• W3150909418 hasAuthorship W3150909418A5042202815 @default.
• W3150909418 hasAuthorship W3150909418A5054861001 @default.
• W3150909418 hasAuthorship W3150909418A5059592567 @default.
• W3150909418 hasAuthorship W3150909418A5066266071 @default.
• W3150909418 hasAuthorship W3150909418A5072348796 @default.
• W3150909418 hasAuthorship W3150909418A5074346281 @default.
• W3150909418 hasAuthorship W3150909418A5077000250 @default.
• W3150909418 hasAuthorship W3150909418A5081937285 @default.
• W3150909418 hasAuthorship W3150909418A5084815041 @default.
• W3150909418 hasAuthorship W3150909418A5085121407 @default.
• W3150909418 hasAuthorship W3150909418A5088044598 @default.
• W3150909418 hasAuthorship W3150909418A5089539215 @default.
• W3150909418 hasBestOaLocation W31509094181 @default.
• W3150909418 hasConcept C121608353 @default.
• W3150909418 hasConcept C126322002 @default.
• W3150909418 hasConcept C143998085 @default.
• W3150909418 hasConcept C177713679 @default.
• W3150909418 hasConcept C203014093 @default.

• next